iFIT Cluster of Excellence Newsletter Vol. IX

Dear members,

With our Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence. Vol. IX includes news, publications and general information from the past three months and upcoming events. The next newsletter will be published on December 1, 2025.

If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de

With best regards,

iFIT Office Team

News

iFIT News

4th German Cancer Research Congress with Prof. Walz & Prof. Leibold

iFIT News

New Clinical Trial started against rare liver cancer

iFIT News

Mini Symposium "Silent cells, noisy signals: advancing therapy and imaging of senescence"

iFIT News

Dr. Wimmers on the cover of University Magazine Attempto!

iFIT News

Prof. Rammensee awarded with the Friedrich List Medal in Gold

iFIT News

Prof. Weigelin part of recent article in Attempto!

iFIT News

Dr. Benjamin Ruf receives 2025 Württemberg Cancer Prize

iFIT News

Stefan Zwirner successfully defended his doctorate!

Upcoming Events

Lunch & Learn

iFIT Lunch & Learn Session with Lisa Sevenich

17^th of September 2025 at 12:00pm
Lecture hall 210, CRONA Clinics

Distinguished Lecture

iFIT Distinguished Lecture with Luigi Nezi

29^th of September 2025 at 12:00pm
Lecture hall 210, CRONA Clinics

Lunch & Learn

iFIT Lunch & Learn Session with Anna Junker

8^th of October 2025 at 12:00pm
Lecture hall, Psychiatric Clinic

General Assembly

iFIT General Assembly & Scientific Symposium

15^th of October

tbd

Distinguished Lecture

iFIT Distinguished Lecture with Leila Akkari

20^th of October 2025

tbd

Lunch & Learn

iFIT Lunch & Learn Session with Luidmila Andreeva

5^th of November 2025
tbd

Distinguished Lecture

iFIT Distinguished Lecture with Natalie Köhler

24^th of November 2025

tbd

Symposium

iFIT Merry Science Symposium

3^rd of December 2025
tbd

Selected Publications

PET-based immunomapping of intratumoral CD4+ cells to monitor acquired resistance to checkpoint inhibitors

Stefania Pezzana et al. PET-based immunomapping of intratumoral CD4+ cells to monitor acquired resistance to checkpoint inhibitors.Sci. Adv.11,eadw1924(2025). 10.1126/sciadv.adw1924 IF: 12.5

A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2

Laura Hillebrand et al. A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2. RSC Med Chem (2025).  10.1039/d5md00440c   IF: 3.6

Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer

Sylwia Stefanczyk et al. Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer. Front Immunol. 2025 Jul 31:16:1624751. 10.3389/fimmu.2025.1624751 IF: 5.9

T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer

[...], Melanie Märklin et al. T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer. J Transl Med. 2025 Jul 24;23(1):825. 10.1186/s12967-025-06825-4  IF: 7.5

Mixed acinar cell carcinoma/non-ampullary adenocarcinoma of the duodenum 

[...], Christian Schürch et al. Mixed acinar cell carcinoma/non-ampullary adenocarcinoma of the duodenum. Pathology 2025 Jun 16:S0031-3025(25)00182-5.

10.1016/j.pathol.2025.04.006 IF: 3.7

Job Offers

Medical Assistant for Immunotherapies (f/m/d)

University Hospital of Tuebingen - Medical Clinic, CCU Translational Immunology

Follow us on social media

Legal Notice

Cluster of Excellence

“Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076  Tübingen, Germany

Contact:

Public Relations
Steven Pohl

Mail: steven.patrick.pohl@med.uni-tuebingen.de

Click here to unsubscribe